This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
Last Updated: 11/07/2024
Your healthcare provider may reduce your dose, temporarily stop, or permanently stop treatment with ERLEADA if you have certain side effects.1
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.1
See the ERLEADA PATIENT INFORMATION for information on other common side effects of ERLEADA. This is not the only possible side effect of ERLEADA.1
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.1
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.
Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for ERLEADA.1
1 | ERLEADA (apalutamide) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ERLEADA-pi.pdf |